RJA
CHN

Raymond James & Associates’s China Fund CHN Stock Holding History

Raymond James & Associates’s Portfolio CHN Stock Details CHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-19,424
Closed -$355K – 4139
2021
Q4 		$355K Hold
19,424
– – ﹤0.01% 3339
2021
Q3 		$494K Sell
19,424
-14,270
-42% -$395K ﹤0.01% 3071
2021
Q2 		$1.03M Sell
33,694
-149
-0.4% -$4.41K ﹤0.01% 2574
2021
Q1 		$991K Sell
33,843
-39
-0.1% -$1.22K ﹤0.01% 2520
2020
Q4 		$968K Sell
33,882
-2,139
-6% -$61.3K ﹤0.01% 2373
2020
Q3 		$907K Hold
36,021
– – ﹤0.01% 2228
2020
Q2 		$804K Hold
36,021
– – ﹤0.01% 2305
2020
Q1 		$665K Sell
36,021
-1,198
-3% -$24.4K ﹤0.01% 2233
2019
Q4 		$785K Sell
37,219
-1,075
-3% -$22.1K ﹤0.01% 2428
2019
Q3 		$743K Sell
38,294
-4,400
-10% -$87.4K ﹤0.01% 2376
2019
Q2 		$864K Buy
42,694
+1,899
+5% +$38.1K ﹤0.01% 2301
2019
Q1 		$831K Sell
40,795
-5,972
-13% -$114K ﹤0.01% 2317
2018
Q4 		$790K Buy
46,767
+2,443
+6% +$43.4K ﹤0.01% 2225
2018
Q3 		$869K Sell
44,324
-2,000
-4% -$40K ﹤0.01% 2339
2018
Q2 		$968K Hold
46,324
– – ﹤0.01% 2243
2018
Q1 		$1.03M Sell
46,324
-27
-0.1% -$613 ﹤0.01% 2114
2017
Q4 		$1M Sell
46,351
-5,423
-10% -$115K ﹤0.01% 2126
2017
Q3 		$1.05M Sell
51,774
-7,700
-13% -$153K ﹤0.01% 2060
2017
Q2 		$1.11M Sell
59,474
-30,816
-34% -$549K ﹤0.01% 1966
2017
Q1 		$1.5M Sell
90,290
-228
-0.3% -$3.66K ﹤0.01% 1713
2016
Q4 		$1.36M Sell
90,518
-172
-0.2% -$2.71K ﹤0.01% 1748
2016
Q3 		$1.49M Buy
90,690
+20,220
+29% +$317K ﹤0.01% 1640
2016
Q2 		$1.02M Sell
70,470
-100
-0.1% -$1.43K ﹤0.01% 1724
2016
Q1 		$1.04M Sell
70,570
-4,200
-6% -$58K ﹤0.01% 1652
2015
Q4 		$1.16M Buy
74,770
+5,200
+7% +$88.2K ﹤0.01% 1560
2015
Q3 		$1.11M Buy
69,570
+1,440
+2% +$24.7K ﹤0.01% 1542
2015
Q2 		$1.35M Buy
68,130
+9,460
+16% +$201K 0.01% 1563
2015
Q1 		$1.14M Buy
58,670
+4,000
+7% +$75.6K 0.01% 1587
2014
Q4 		$997K Sell
54,670
-2,000
-4% -$41.8K ﹤0.01% 1578
2014
Q3 		$1.18M Buy
56,670
+2,700
+5% +$59.2K 0.01% 1399
2014
Q2 		$1.14M Buy
53,970
+6,400
+13% +$130K 0.01% 1417
2014
Q1 		$947K Buy
47,570
+1,300
+3% +$25.9K 0.01% 1458
2013
Q4 		$963K Buy
46,270
+14,300
+45% +$322K 0.01% 1354
2013
Q3 		$694K Sell
31,970
-1,400
-4% -$29.5K 0.01% 1438
2013
Q2 		$667K Buy
+33,370
New +$692K 0.01% 1364

Other funds holding CHN

COLIM
City of London Investment Management London, United Kingdom $1.66B AUM 59.71% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
IR
IAT Reinsurance New York $310M AUM 13.37% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
SFS
Shaker Financial Services Arlington, Virginia $319M AUM 3.9% 1-Year Est. Return
BWA
BDO Wealth Advisors Jacksonville, Florida $872M AUM 15.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James & Associates's CHN Position: Q1 2022 in Review

Raymond James & Associates sold out of China Fund (CHN) in Q1 2022, closing a stake of 19,424 shares — an estimated $355K sold.

Raymond James & Associates first reported a position in CHN in Q2 2013 and held it in 35 quarters. The position peaked at $1.5M in Q1 2017. 30 funds tracked by Wall St. Rank hold CHN as of Q1 2022.

  • Raymond James & Associates reported no remaining China Fund position as of Q1 2022 after selling out during the quarter.
  • Raymond James & Associates sold 19,424 China Fund shares in Q1 2022, an estimated $355K.
  • Raymond James & Associates first reported a position in China Fund in Q2 2013 and held it in 35 quarters.
  • Raymond James & Associates's China Fund position peaked at $1.5M in Q1 2017.
  • 30 funds tracked by Wall St. Rank held China Fund as of Q1 2022.

Based on Raymond James & Associates's 13F filing for Q1 2022, filed 11 May 2022.